Black Friday

All the Features.
Half the Price.

$149.00 / first year $299.50

Then $299.50/year

Last Close
10.62
Nov 12 • 3:59 PM ET Dollar change-1.29 Percentage change(-10.83%)
Aftermarket Close
10.62
Aftermarket • 5:00 PM ET Dollar change0.00 Percentage change(0.00%)
Index
RUT
Market Cap
728.67M
Enterprise Value
3.68B
Income
-369.20M
Sales
2.59B
Book/sh
26.11
Cash/sh
2.43
Dividend Est.
-
Dividend TTM
-
Dividend Ex-Date
-
Dividend Gr. 3/5Y
- -
Payout
-
Employees
6500
IPO
Feb 01, 1991
P/E
-
Forward P/E
8.08
PEG
-
P/S
0.28
P/B
0.41
P/C
4.38
P/FCF
-
EV/EBITDA
9.23
EV/Sales
1.42
Quick Ratio
0.75
Current Ratio
1.36
Debt/Eq
1.74
LT Debt/Eq
1.48
Option/Short
Yes / Yes
EPS (ttm)
-5.41
EPS next Y
1.31
EPS next Q
0.26
EPS this Y
-68.63%
EPS next Y
97.74%
EPS next 5Y
-6.82%
EPS past 3/5Y
- -
Sales past 3/5Y
-5.81% 10.42%
EPS Y/Y TTM
68.20%
Sales Y/Y TTM
-4.64%
EPS Q/Q
92.74%
Sales Q/Q
-11.71%
Insider Own
0.90%
Insider Trans
0.00%
Inst Own
116.93%
Inst Trans
-9.57%
ROA
-6.45%
ROE
-19.29%
ROIC
-8.29%
Gross Margin
37.01%
Oper. Margin
-2.43%
Profit Margin
-14.25%
SMA20
-18.84%
SMA50
-14.17%
SMA200
-31.30%
Trades
Shs Outstand
68.60M
Shs Float
68.00M
52W High
35.58 -70.15%
52W Low
9.92 7.06%
Volatility
14.49% 9.92%
ATR (14)
1.23
RSI (14)
38.17
Beta
0.80
Rel Volume
0.76
Avg Volume
1.90M
Volume
1,436,344
Perf Week
-17.29%
Perf Month
-23.43%
Perf Quarter
-25.73%
Perf Half Y
-6.76%
Perf YTD
-62.82%
Perf Year
-52.99%
Perf 3Y
-82.10%
Perf 5Y
-92.61%
Perf 10Y
-51.71%
Prev Close
11.91
Price
10.62
Change %
-10.83%
Consensus
Hold
Avg. Price Target
$15.00
Implied Upside
+41.2%
Analysts8incl. previous ratings
Rating Distribution3 Buy · 4 Hold · 1 Sell
DateActionAnalystRating ChangePrice Target ChangeImplied Upside
May 07, 2026Downgrade
JEF logoJJefferies
Buy → Hold$12.50+17.7%
Oct 07, 2025Downgrade
C logoCCitigroup
Buy → Neutral$33+210.7%
May 08, 2025Upgrade
JEF logoJJefferies
Hold → Buy$44+314.3%
Dec 11, 2024Upgrade
C logoCCitigroup
Neutral → Buy$44 → $50+370.8%
Dec 10, 2024Initiated
JEF logoJJefferies
Hold$43+304.9%
Sep 19, 2024Resumed
UBS logoUUBS
Neutral$42 → $50+370.8%
Sep 05, 2024Upgrade
CCraig Hallum
Hold → Buy$40 → $57+436.7%
Mar 04, 2024Downgrade
UBS logoUUBS
Neutral → Sell$70 → $42+295.5%
Feb 14, 2024Downgrade
JPM logoJJP Morgan
Neutral → Underweight$66 → $37+248.4%
Dec 11, 2023Downgrade
C logoCCitigroup
Buy → Neutral$95 → $72+578.0%
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Siegrist Jonathan PhilipEVP of R&D & CTOOct 15 '26Option Exercise0.0018,657032,076Oct 19 05:07 PM
Bowman Ronald LeeChief Human Resources OfficerSep 15 '26Option Exercise0.002,56605,941Sep 17 06:32 PM
Hanson Bryan MichaelEVP Global Port. Mgmt & MktingAug 15 '26Option Exercise0.0044608,217Aug 18 04:14 PM
Hanson Bryan MichaelEVP Global Port. Mgmt & MktingJul 01 '26Option Exercise0.005,79709,867Jul 02 04:06 PM
Strobeck MatthewDirectorFeb 13 '26Buy23.9610,000239,58627,775Feb 13 04:20 PM
Busky Joseph M.Chief Financial OfficerFeb 13 '26Buy23.663,37079,74210,290Feb 13 12:44 PM
Blaser Brian J.President and CEOFeb 13 '26Buy23.5910,540248,66140,073Feb 13 10:43 AM
RHOADS ANN DDirectorDec 10 '25Buy28.2775021,20615,021Dec 10 06:37 PM
Wilkins Joseph D Jr.DirectorNov 26 '25Buy27.9537010,34311,876Dec 01 04:33 PM
WIDDER KENNETH JDirectorNov 25 '25Option Exercise15.747,021110,51141,087Nov 25 04:16 PM
WIDDER KENNETH JDirectorNov 25 '25Sale27.814,026111,96537,061Nov 25 04:16 PM
KENNETH WIDDERDirectorNov 25 '25Proposed Sale27.814,026111,965Nov 25 04:11 PM
Busky Joseph M.Chief Financial OfficerNov 24 '25Buy26.064,770124,3056,920Nov 25 01:21 PM
POLAN MARY LAKE PH DDirectorNov 21 '25Buy22.431,00022,43012,640Nov 24 04:09 PM
Blaser Brian J.President and CEONov 19 '25Buy21.3423,500501,57729,533Nov 20 04:16 PM
QuidelOrtho Corp. operates as a vitro diagnostics company. It is focused on developing and manufacturing diagnostic products. The company was founded on May 27, 2022 and is headquartered in San Diego, CA.
PresidentMr. Brian J. Blaser
Chief Operations OfficerMr. Philip D. McLellan
Executive VP of Research & Development and CTOMr. Jonathan P. Siegrist Ph.D.
Chief Financial Officer & Principal Financial OfficerMr. Micah Young CPA
Vice President of Investor RelationsMs. Juliet C. Cunningham